Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers.
about
Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcomeTranscriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate.Development of a novel high-throughput screen and identification of small-molecule inhibitors of the Gα-RGS17 protein-protein interaction using AlphaScreen.Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancerGenetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma.Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progressionDeregulation of RGS17 Expression Promotes Breast Cancer Progression.Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survivalGenetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancerRGS2 suppresses breast cancer cell growth via a MCPIP1-dependent pathway.Role of p115RhoGEF in the regulation of extracellular Ca(2+)-induced choline kinase activation and prostate cancer cell proliferation.Ischemia induces regulator of G protein signaling 2 (RGS2) protein upregulation and enhances apoptosis in astrocytes.Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells.Downregulation of regulator of G protein signaling 2 expression in breast invasive carcinoma of no special type: Clinicopathological associations and prognostic relevance.
P2860
Q27318509-7670C044-DDAA-437A-B304-8B47C99E4A6AQ33390756-95498C0F-0CD7-4654-A765-17B8B44BF3A4Q33926024-2888CD2F-E50F-4D02-8591-B20BC71FD00EQ33940693-0FFF1D36-6D66-4479-AF68-67E0BB6AE089Q34180253-750563D5-882E-4BE7-BAA9-7BD4AE7491BAQ34304234-84EFECA2-287E-4874-9FFD-2F55C33BD484Q35856860-8B1B0275-F1D9-4045-8114-63508F44FF57Q37139815-DDCF8CBA-E6BD-456F-AA73-E86804A85A3BQ37731815-7F549E4B-908D-4D08-A8BA-7B0187DD9C21Q38960056-6C93BA28-6FC1-431F-8602-3DB49B290041Q39664054-884428B2-2C59-481C-8F86-F9D4FB18373DQ39759467-ECE06173-8406-4F5A-9FFB-6A778FF86743Q39764882-22E03364-1FD3-4AB3-B7CD-89979E110103Q42276895-017D4B64-703A-462F-BF01-B01D879EECEEQ49387003-5804FAB7-9419-4825-A939-166438ED446A
P2860
Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Regulator of G-protein signall ...... he majority of breast cancers.
@ast
Regulator of G-protein signall ...... he majority of breast cancers.
@en
type
label
Regulator of G-protein signall ...... he majority of breast cancers.
@ast
Regulator of G-protein signall ...... he majority of breast cancers.
@en
prefLabel
Regulator of G-protein signall ...... he majority of breast cancers.
@ast
Regulator of G-protein signall ...... he majority of breast cancers.
@en
P2093
P2860
P50
P356
P1476
Regulator of G-protein signall ...... he majority of breast cancers.
@en
P2093
Alan Mackay
Howard Kendrick
Kerry Fenwick
Marjan Iravani
Sarah McDonald
Tim Dexter
P2860
P2888
P356
10.1186/BCR1834
P50
P577
2007-01-01T00:00:00Z